Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125654321 | 12565432 | 1 | I | 20160617 | 20160718 | 20160718 | EXP | ES-ACTAVIS-2016-15644 | ACTAVIS | MARTIN AJM, ALFONSO PG, RUPEREZ AB, JIMENEZ MM. NAB-PACLITAXEL PLUS GEMCITABINE AS FIRST-LINE PALLIATIVE CHEMOTHERAPY IN A PATIENT WITH METASTATIC PANCREATIC CANCER WITH EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS OF 2. ONCOL LETT. 2016;12(1):727-730. | 65.00 | YR | F | Y | 0.00000 | 20160718 | MD | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125654321 | 12565432 | 1 | PS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | DAYS 1, 8 AND 15 (3 CYCLES) | U | UNCONFIRMED | 79160 | 1000 | MG/M**2 | UNK | |||||
| 125654321 | 12565432 | 2 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | DAYS 1, 8 AND 15 | U | UNCONFIRMED | 79160 | 1000 | MG/M**2 | UNK | |||||
| 125654321 | 12565432 | 3 | SS | TEGAFUR | TEGAFUR | 1 | Oral | THROUGHOUT RADIOTHERAPY TREATMENT AT 1,200 MG/DAY | U | 0 | 1200 | MG | |||||||
| 125654321 | 12565432 | 4 | C | LETROZOLE. | LETROZOLE | 1 | Oral | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125654321 | 12565432 | 1 | Adenocarcinoma pancreas |
| 125654321 | 12565432 | 3 | Adenocarcinoma pancreas |
| 125654321 | 12565432 | 4 | Breast cancer stage I |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125654321 | 12565432 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125654321 | 12565432 | Anaemia | |
| 125654321 | 12565432 | Asthenia | |
| 125654321 | 12565432 | Biliary tract disorder | |
| 125654321 | 12565432 | Cholangitis acute | |
| 125654321 | 12565432 | Diabetes mellitus | |
| 125654321 | 12565432 | Enteritis | |
| 125654321 | 12565432 | Neutropenia | |
| 125654321 | 12565432 | Pancreatic insufficiency |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |